XML 167 R38.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes (Tables)
9 Months Ended 12 Months Ended
Jun. 30, 2025
Sep. 30, 2024
Income Taxes [Abstract]    
Schedule of Components of the Company’s Income Tax Provision

The components of the Company’s income tax provision were as follows for the period indicated:

 

   For the
three months
ended
June 30,
2025
   For the
three months
ended
June 30,
2024
   For the
nine months
ended
June 30,
2025
   For the
nine months
ended
June 30,
2024
 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Current  $             -   $               -   $             -   $             - 
Deferred   -    -    -    - 
Total income tax expense  $-   $-   $
 
   $
 
 

The components of the Company’s income tax provision were as follows for the period indicated:

 

    For the year
ended
September 30,
2024
    For the year
ended
September 30,
2023
 
           
Current  $-   $- 
Deferred   -    - 
Total income tax provision  $-   $- 
Schedule of Malaysia Statutory Rates to the Company’s Effective Tax Rate  

The following table reconciles Malaysia statutory rates to the Company’s effective tax rate:

 

   For the year
ended
September 30,
2024
   For the year
ended
September 30,
2023
 
         
Malaysia income tax rate   24.0%   24.0%
Change in valuation allowance   (24.0)%   (24.0)%
Effective tax rate   -%   -%
Schedule of Significant Components of the Aggregate Deferred Tax Assets and Liabilities

The following table sets forth the significant components of the aggregate deferred tax assets and liabilities of the Company as of:

 

   June 30,
2025
(unaudited)
   September 30,
2024
 
         
Deferred Tax Assets:        
Net operating loss carry-forwards  $4,876,038   $4,406,475 
Capital allowances   150,591    105,298 
Less: valuation allowance   (5,026,629)   (4,511,773)
Deferred tax assets, net   -    - 
Deferred tax liabilities:          
Capitalized R&D expenses   -    - 
Deferred tax (liabilities) assets, net  $-   $- 

The following table sets forth the significant components of the aggregate deferred tax assets and liabilities of the Company as of:

 

   September 30,
2024
   September 30,
2023
 
         
Deferred Tax Assets:        
Net operating loss carry-forwards  $4,406,475   $281,694 
Capital allowances   105,298    132 
Less: valuation allowance   (4,511,773)   (281,826)
Deferred tax assets, net   -    - 
Deferred tax liabilities:          
Capitalized R&D expenses   -    - 
Deferred tax (liabilities) assets, net  $-   $- 
Schedule of Movement of Valuation Allowance

Movement of valuation allowance:

 

   June 30,
2025
(unaudited)
   September 30,
2024
 
         
Balance at beginning of the year  $4,511,773   $281,826 
Addition   514,856    4,229,947 
Balance at end of the year  $5,026,629   $4,511,773 

Movement of valuation allowance:

 

   September 30,
2024
   September 30,
2023
 
         
Balance at beginning of the year  $281,826   $- 
Addition   4,229,947    281,826 
Balance at end of the year  $4,511,773   $281,826